{"name":"Immix Biopharma","slug":"immix","ticker":"IMMX","exchange":"NASDAQ","domain":"immixbio.com","description":"Immix Biopharma is a biopharmaceutical company focused on developing tissue-targeted therapeutics for rare diseases. The company's pipeline includes several promising candidates, with a strong emphasis on addressing unmet medical needs. With a growing portfolio of assets, Immix Biopharma is well-positioned to make a meaningful impact in the rare disease space. As a relatively small player in the industry, the company's market position is still evolving, but its commitment to innovation and patient care is clear.","hq":"Los Angeles, CA","founded":0,"employees":"","ceo":"Ilya Bharat Rachman","sector":"Tissue-Targeted Therapeutics / Rare Disease","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$65M","metrics":{"revenue":20000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":16258598,"netIncome":-29438613,"cash":93928566,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2022"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2030-06-01","label":"IMMX-101 patent cliff ($0.0B at risk)","drug":"IMMX-101","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Immix Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Immix Biopharma reported its financial results for the fourth quarter and full year 2023, with a focus on its pipeline development and commercial progress.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"Immix Biopharma Announces Collaboration with Leading Research Institution","summary":"Immix Biopharma entered into a collaboration with a leading research institution to advance its pipeline development and explore new therapeutic opportunities.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-03-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-25","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE54eXBMTFR6NEVkNTZIOVJseE5tMDdHa1dQZXN6RVVvRnlGTmpsb3Z3bFhIN0RSY3FxWksza2lpWjZOYUpIUDUtNmZNcGFWN1I0cmlFWFNuN3FnNkxGaUZWZWxfeWhHN25vWDNKN29R?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Immix Biopharma Inc (IMMX) - Stock Titan","headline":"If You Invested $1,000 in Immix Biopharma Inc (IMMX)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-16","type":"pipeline","source":"simplywall.st","summary":"Analysts Expect Breakeven For Immix Biopharma, Inc. (NASDAQ:IMMX) Before Long - simplywall.st","headline":"Analysts Expect Breakeven For Immix Biopharma, Inc. (NASDAQ:IMMX) Before Long","sentiment":"neutral"},{"date":"2025-12-08","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOeHNIQUxwODJ5NWZHaDRseThRQUZCOGFMdVdYemZCSlNFYldnaWExZnhPTEtWMlU0VGFVa191Y3RFc29zdGdnRWpZS1dDS1JaWU9sRW5UNzZ4MDA3WVd5Uktkd1d1aXdpZWx6MlBjbkV5ZU9DT0NTVnAxZFB6akVLVmtKU3ZnQkpEd1hxNzFVTTh6clZ1LUc5WlU3M2pDVDRRSnU1anhfRHo2b3h3ekZXUHZqWjg0cU45T204blZaWlZ4eE1ueFloUWZiZmkwQWFTcEJTZTB2QUdjMGFSNEtCXzd4WdIB6AFBVV95cUxQeWJmMlFwbXJhTmZHMG0zUUpZLS0tUjFIRWMxU3hLOGI1MVZ2bmZBRGc2Z2hBc0hIeUdRdkgzVmUyekdxeWE5SmxwV2RRaWFCOERXSGFxeUc2SWtIRXh4dk11alBmNzN3eVFRc1k0ck05QU9yNmwwajhWelBMS2JjRlJVOUl5dk52VTN4aXVaMk5OZU1VbjBNMEo0NjU4RWdXM2JQcU05Vmp0NWdqRElJQmtYM2JUV1h3ZjlOVTAyWVdKbWJOaDNfcmduUG92Tk8yMEh2NmQxUFJWSTJmT1BudXlmX1poaWx5?oc=5","date":"2025-12-05","type":"earnings","source":"simplywall.st","summary":"Immix Biopharma, Inc.'s (NASDAQ:IMMX) market cap rose US$18m last week; retail investors who hold 56% profited and so did insiders - simplywall.st","headline":"Immix Biopharma, Inc.'s (NASDAQ:IMMX) market cap rose US$18m last week; retail investors who hold 56% profited and so di","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-27","type":"pipeline","source":"simplywall.st","summary":"Immix Biopharma Insider Confidence Rewarded, Stock Hits US$118m Market Cap - simplywall.st","headline":"Immix Biopharma Insider Confidence Rewarded, Stock Hits US$118m Market Cap","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-13","type":"pipeline","source":"simplywall.st","summary":"We Think Immix Biopharma (NASDAQ:IMMX) Needs To Drive Business Growth Carefully - simplywall.st","headline":"We Think Immix Biopharma (NASDAQ:IMMX) Needs To Drive Business Growth Carefully","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFBpTXM2T3FWbi1PSlhDeDZDUlZoWktmMzNVR2ViMHJFN3pzYnBXNVFQeXgxbnZTejEtYkFHZ1ROM3hWamtaWExwWWwtWTR5SzZLQWtYcnhIeDNlWXFGNUJzMkxGVnJkWGxa?oc=5","date":"2025-07-09","type":"regulatory","source":"MarketBeat","summary":"Immix Biopharma (IMMX) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat","headline":"Immix Biopharma (IMMX) FDA Approvals, PDUFA Dates & Drug Alerts 2026","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE5SbTdtQk93YUZEUUV2WGtQMk0yUmlSbmoxMHhEUnN2czJQRDhGNXBhLWRBbjVGYzJuZThpcndfWFB6RlhnUjk0VlJkeGRQcVl4?oc=5","date":"2024-01-06","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE14blZZS2hLazNkeW12ZG5GZnRfcUNzcGQzNS1DRXB0VDY1RjgtMjd4RGpLUDdROG50ZHlkTHpYbXVpVndPcmU0MkZmLUtRLS1qay1WYm1Oa1hOTzd6?oc=5","date":"2021-12-16","type":"pipeline","source":"TradingView","summary":"IMMX Stock Price and Chart — NASDAQ:IMMX - TradingView","headline":"IMMX Stock Price and Chart — NASDAQ:IMMX","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBUOS1yX3pyd1hvXzVub0N1ajM3cVZicDl4eXVWbW5PS05FN2p2WXYyNUhZLW9tM2RuVkVfejc0ZGRIRWVZdlJhVXFaUnBQd3dMZXZXN0hWY2pFSjdxLW1v?oc=5","date":"2019-07-23","type":"pipeline","source":"Benzinga","summary":"Best Biotech Stocks Right Now • Updated Daily - Benzinga","headline":"Best Biotech Stocks Right Now • Updated Daily","sentiment":"neutral"}],"patents":[{"drugName":"IMMX-101","drugSlug":"generic-name-not-publicly-disclosed","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":0}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["BioMarin Pharmaceutical Inc.","Sarepta Therapeutics, Inc.","Pfizer Inc."],"therapeuticFocus":["Rare Diseases","Tissue-Targeted Therapeutics"],"financials":{"source":"sec_edgar+yahoo","revenue":20000000,"revenuePeriod":"2022-12-08","revenueHistory":[{"value":20000000,"period":"2022-12-08"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":16258598,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-29438613,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":93928566,"cashHistory":[],"totalAssets":104840341,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}